Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jian-Hua Luo

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|February 13, 2003
Gene expression alterations in human prostate cancerJian-Hua Luo
World Journal of Clinical Oncology|May 24, 2011
Oncogenic activity of MCM7 transforming clusterJian-Hua Luo
Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology|December 24, 2008
[Treatment of anterior dislocation of shoulder joint with manipulative method]Jian-hua Luo
Expert Reviews in Molecular Medicine|October 31, 2003
Genetic factors underlying prostate cancerJian-Hua Luo, Yan Ping Yu
Sensors (Basel, Switzerland)|April 13, 2018
Pure FPGA Implementation of an HOG Based Real-Time Pedestrian Detection SystemJian Hua Luo, Chang Hong Lin
Cancer Research|August 4, 2006
Myopodin-mediated suppression of prostate cancer cell migration involves interaction with zyxinYan Ping Yu, Jian-Hua Luo
Cancer Science|December 17, 2009
(-)-Epigallocatechin-3-gallate induces Du145 prostate cancer cell death via downregulation of inhibitor of DNA binding 2, a dominant negative helix-loop-helix proteinKatherine L Luo, Jian-Hua Luo, Yan P Yu
Urology|September 19, 2006
Inactivation of myopodin expression associated with prostate cancer relapseYan Ping Yu, George C Tseng, Jian-Hua Luo
The American Journal of Pathology|March 27, 2024
Serum Fusion Transcripts to Assess the Risk of Hepatocellular Carcinoma and the Impact of Cancer Treatment through Machine LearningYan-Ping Yu, Silvia Liu, David Geller, et al.
Acta Biochimica Et Biophysica Sinica|March 10, 2005
Protein secondary structure prediction using dynamic programmingJing Zhao, Pei-Ming Song, Qing Fang, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Drugs of Today (Barcelona, Spain : 1998)|February 13, 2003
Gene expression alterations in human prostate cancerJian-Hua Luo
World Journal of Clinical Oncology|May 24, 2011
Oncogenic activity of MCM7 transforming clusterJian-Hua Luo
Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology|December 24, 2008
[Treatment of anterior dislocation of shoulder joint with manipulative method]Jian-hua Luo
Expert Reviews in Molecular Medicine|October 31, 2003
Genetic factors underlying prostate cancerJian-Hua Luo, Yan Ping Yu
Sensors (Basel, Switzerland)|April 13, 2018
Pure FPGA Implementation of an HOG Based Real-Time Pedestrian Detection SystemJian Hua Luo, Chang Hong Lin
Cancer Research|August 4, 2006
Myopodin-mediated suppression of prostate cancer cell migration involves interaction with zyxinYan Ping Yu, Jian-Hua Luo
Cancer Science|December 17, 2009
(-)-Epigallocatechin-3-gallate induces Du145 prostate cancer cell death via downregulation of inhibitor of DNA binding 2, a dominant negative helix-loop-helix proteinKatherine L Luo, Jian-Hua Luo, Yan P Yu
Urology|September 19, 2006
Inactivation of myopodin expression associated with prostate cancer relapseYan Ping Yu, George C Tseng, Jian-Hua Luo
The American Journal of Pathology|March 27, 2024
Serum Fusion Transcripts to Assess the Risk of Hepatocellular Carcinoma and the Impact of Cancer Treatment through Machine LearningYan-Ping Yu, Silvia Liu, David Geller, et al.
Acta Biochimica Et Biophysica Sinica|March 10, 2005
Protein secondary structure prediction using dynamic programmingJing Zhao, Pei-Ming Song, Qing Fang, et al.
Pageof 10